ICiDO 3

WWIW MMS

670/ 8

SA: W Nos

Patient Name: 66 (>9 ‘7

9%) 5/12/13

Requested By:

Ordered By:
“9°“ "ame‘ uum: arse1cs7- Am- 4319- sscu- 2AAF379ACB7e9
TCGA- MZ- ASBI- 01A- PR
------------------------------------------------------------------------------- |||||||||||||||||||||IIllllll|Illlll|lllllllllllllIllllllllllllllll
“‘9 Path Cm ' STATUS= “n“ Ill|||||lllllllllllllllllllllllll ”III"
”SEE m“ “mm“"mm Ill ||||||||||lIll|||||||||IllI|||||||||||||||lllllllllllllllllll
Ordered By: Ordered Date:
Facility: Department; PATH

Physician who Performed Procedure:

Requesting Physician:

SURGICAL PATHOLOGY.

DIAGNOSIS:

Left tonsil, eXCisional biopsy:
- Infiltrating squamous cell carcinoma, transitional type. See comment.

COMMENT:
Patient is part of an ins-approved research protocol, ID-

========emu-n...--u-unu-Islz==:=::==-:.----n====== --------- =====xsununn===

CLINICAL INFORMATION:

Ayeaz‘old male with a preop diagnosis of tonsil mass.

GROSS DESCRIPTION:

Received fresh and labeled "left tonsillar mass" in a 3.2 x 2.2 x 2,0
cm, red-tan, irregular, rubbery, lobulated tissue. The specimen is
serially sectioned to reveal tan-red, lobulated, rubbery cut surfaces.

The specimen is submitted entirely in four cassettes.

HElectronic Signature**

Vajc Inna?

Patient Name:

Requested By:
Ordered By:

Report Name: :

The Attending Pathologist reviewed this case and made the diagnosis.

where applicable, immunohistochemistry and in situ hybridization tests
were developed and the performance characteristics determined by the

These tests
have not been cleared or approved by the US Food and Drug Administration
and the results should be correlated with other clinical and laboratory
data. Appropriate controls were performed for all immunohistochemietry,
in situ hybridization and histochemical tests.

   
 
 
 
   

Criteria

Diagnosis Diaciepnuny I _‘_ .—
Prim aw Tumor Sue Discrepancy ’
SM’ﬂf , _
. HIPAA Discrepaniy

‘7 Pnn‘rkmgnancy Hmlory ‘
WV

‘ Dual/Synchronous P‘ "“3”
Case is uncle):

 

 

